OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Release Date
2020
(16)
2018
(2)
2017
(2)
2025
(1)
2024
(1)
2022
(1)
2015
(1)
2012
(1)
2010
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
Not available
S-EPMC5687509
|
biostudies-literature
Cite
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Not available
S-EPMC3071495
|
biostudies-literature
Cite
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Not available
S-EPMC4422053
|
biostudies-literature
Cite
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
Not available
S-EPMC6568257
|
biostudies-literature
Cite
Comprehensive genomic characterization of squamous cell lung cancers.
Not available
S-EPMC3466113
|
biostudies-literature
Cite
Prospects for observing and localizing gravitational-wave transients with Advanced LIGO, Advanced Virgo and KAGRA.
Not available
S-EPMC5920066
|
biostudies-literature
Cite
Who, if anyone, may benefit from a total hip arthroplasty after a displaced femoral neck fracture?: a post hoc subgroup analysis of the HEALTH trial.
Not available
S-EPMC9422900
|
biostudies-literature
Cite
Vasopressor use after noncardiac surgery: an international observational study.
Not available
S-EPMC12799376
|
biostudies-literature
Cite
The landscape of viral associations in human cancers.
Not available
S-EPMC8076016
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets